L'EQ Score indique l'activité et l'attractivité de l'entreprise sur la plateforme : complétude du profil, actualités, likes, follows, appartenance à un ou plusieurs labels ou communautés, nombre de membres de son réseau, etc.
PKvitality is developing K'Watch Glucose, a painless Continuous Glucose Monitoring device in a form of a smartwatch. Completely invisible to others, K'Watch will help diabetics to better control their disease and check their glucose level discreetly.
Le Kremlin-Bicêtre, Île-de-France, France
Send a message
PKvitality is thrilled to have been selected as one of the 12 startups to present its innovative solution at ATTD, the International Conference on Advanced Technologies and Treatments for Diabetes in Madrid, Spain, from the 19th to 22nd of February 2020. ATTD 2020 showcase the latest, world-changing innovations and research in Technologies & Treatments for Diabetes.
Our General Manager, Minh Lê, and Medical CTO, Tom Bishop, have met many main players in the healthcare ecosystem to discuss the challenges of diabetes, including diabetologists, caregivers, specialists… We have presented technical details of K’Watch Glucose, with a great interest raised among them and many useful feedbacks.
Paris, November 25, 2019 –PKvitality, a French company specialized in MedTechdeveloping a CGM smartwatch, announces the creation of its advisory board, consisting of John Brooks, the creator of tubeless insulin pump and Alexandre Richard, the director of corporate M&A at Sanofi.
Paris, November 25, 2019 – Pkvitality, a French company specialized in MedTech, has joined Dassault Systèmes' 3DEXPERIENCE Lab Program, making Dassault Systèmes its official partner for IT applications for the development of K'Watch project, a Continuous Glucose Monitor (CGM) in a form of a smartwatch.
Paris, December 04, 2019 – PKvitality, a French company specialized in bio wearables, was awarded first position in Medtech category in European Health Catapult held on 2 and 3 December 2019 at Paris.PKvitality is currently working on the development of K'Watch project, a Continuous Glucose Monitor(CGM) in a form of a smartwatch.
Start in 2016
First results of in vivo tests on pigs
CES presence: 6 awards including 1 BEST OF INNOVATION in "Tech for a better world" category
K'Watch announced as a Continuous Glucose Monitoring device
Entering Series A fundraising tour with MedTech and BioTech showcases at San Francisco
to be continued ...